Cisplatin/Durvalumab/Pemetrexed Regimen

Preferred Label : Cisplatin/Durvalumab/Pemetrexed Regimen;

NCIt synonyms : Pemetrexed/Cisplatin Plus Durvalumab; Cisplatin/Pemetrexed/Durvalumab; Cisplatin/Imfinzi/Alimta; Cisplatin-Durvalumab-Pemetrexed; Cisplatin/Durvalumab/Pemetrexed; Durvalumab Plus Cisplatin/Pemetrexed; Cisplatin/Pemetrexed Plus Durvalumab;

NCIt definition : A regimen consisting of cisplatin, durvalumab, and pemetrexed that may be used in the treatment of non-small cell lung cancer (NSCLC).;

Détails

Origin ID

C213247;

chemotherapy_regimen_has_component
- Cisplatin [NCIt concept]
- Durvalumab [NCIt concept]
- Pemetrexed Disodium [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

All resources
or only the major
or use the search engine

recommendations
documents concerning education
documents for patients